Computational methods to support high-content screening: From compound selection and data analysis to postulating target hypotheses

Expert Opinion on Drug Discovery

Volumn 4, Issue 1, 2009, Pages 5-13

  Kümmel, Anne ^a   Gabriel, Daniela ^a   Parker, Christian N ^a   Bender, Andreas ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Compound selection; Data management; High content screening; Image analysis; Multiparametric data analysis; Phenotypic screening

Indexed keywords

COMPARATIVE STUDY; DATA ANALYSIS; HIGH CONTENT SCREENING; HIGH THROUGHPUT SCREENING; IMAGE ANALYSIS; INFORMATION PROCESSING; INTERMETHOD COMPARISON; KOLMOGOROV SMIRNOV TEST; METHODOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 67649095757     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460440802586434     Document Type: Review

References (39)

1. Bertelsen M, Sanfridson A. Inflammatory pathway analysis using a high content screening platform. Assay Drug Dev Technol 2005;3(3):261-271 (Pubitemid 41079124)
2. Rines DR, Tu B, Mariglia L, et al. High-content screening of functional genomic libraries. Methods Enzymo 2006;414:530-565 (Pubitemid 44716240)
3. Lang PT, Kuntz ID, Maggiora GM, et al. Evaluating the high-throughput screening computations. J Biomol Screen 2005;10(7):649-652 (Pubitemid 41476797)
4. Parker CN. McMaster University data-mining and docking competition: computational models on the catwalk. J Biomol Screen 2005;10(7):647-648 (Pubitemid 41476796)
5. Fergus S, Bender A, Spring DR. Assessment of structural diversity in combinatorial synthesis. Curr Op Chem Biol 2005;9(3):304-309 (Pubitemid 40804554)
6. Lajiness MS. Dissimilarity-based compound selection techniques. Perspect Drug Disc Design 1997;7/8:65-84
7. Teig SL. Informative Libraries are More Useful than Diverse Ones. J Biomol Screen 1998;3(2):85-88
8. Spencer RW. Diversity analysis in high throughput screening. J Biomol Screen 1997;2:69-70 (Pubitemid 127689995)
9. Bajorath J. Integration of virtual and high-throughput screening. Nat Rev Drug Discov 2002;1(11):882-894 (Pubitemid 37361583)
10. Bender A, Mussa HY, Glen RC, et al. Molecular similarity searching using atom environments, information-based feature selection, and a naive bayesian classifier. J Chem Inf Comput Sci 2004;44(1):170-178
11. Engels MF, Venkatarangan P. Smart screening: approaches to efficient HTS. Curr Opin Drug Discov Devel 2001;4(3):275-283 (Pubitemid 32499896)
12. Kitchen DB, Decornez H, Furr JR, et al. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 2004;3(11):935-949 (Pubitemid 39529931)
13. Bender A, Glen RC. Molecular similarity: a key technique in molecular informatics. Org Biomol Chem 2004;2(22):3204-3218
14. Johnson M, Maggiora GM, eds. Concepts and Application of Molecular Similarity. New York: John Wiley & Sons 1990
15. Schreyer SK, Parker CN, Maggiora GM. Data shaving: a focused screening approach. J Chem Inf Comput Sci 2004;44(2):470-479
16. Crisman TJ, Jenkins JL, Parker CN, et al. "Plate cherry picking": a novel semi-sequential screening paradigm for cheaper, faster, information-rich compound selection. J Biomol Screen 2007;12(3):320-327 (Pubitemid 46514676)
17. Carpenter AE, Jones TR, Lamprecht MR, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 2006;7:R100 (Pubitemid 46453508)
18. Skylar O, Huber W, Smith M. EBImage: Image analysis and image processing toolkit for R. 2.2.0 edition: Eur Bioinform Inst 2007
19. Denner P, Schmalowsky J, Prechtl S. High-content analysis in preclinical drug discovery. Comb Chem High Throughput Screen 2008;11(3):216-230
20. O'Brien P, Haskins JR. In vitro cytotoxicity assessment. Methods Mol Biol 2007;356:415-425
21. Loo LH, Wu LF, Altschuler SJ. Image-based multivariate profiling of drug responses from single cells. Nat Methods 2007;4(5):445-453 (Pubitemid 46901279)
22. MacDonald ML, Lamerdin J, Owens S, et al. Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol 2006;2(6):329-337 (Pubitemid 43787215)
23. Tanaka M, Bateman R, Rauh D, et al. An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol 2005;3(5):e128 (Pubitemid 40958400)
24. Young DW, Bender A, Hoyt J, et al. Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat Chem Biol 2008;4(1):59-68 (Pubitemid 350273652)
25. Duerr O, Duval F, Nichols A, et al. Robust hit identification by quality assurance and multivariate data analysis of a high-content, cell-based assay. J Biomol Screen 2007;12(8):1042-1049 (Pubitemid 350179703)
26. Lansing Taylor D, Giuliano KA. Multiplexed high content screening assays create a systems cell biology approach to drug discovery. Drug Discovery Today Technol 2005;2(2):149-154 (Pubitemid 40946322)
27. Giuliano KA, Chen YT, Taylor DL. High-content screening with siRNA optimizes a cell biological approach to drug discovery: defining the role of P53 activation in the cellular response to anticancer drugs. J Biomol Screen 2004;9(7):557-568 (Pubitemid 40503514)
28. Perlman ZE, Slack MD, Feng Y, et al. Multidimensional drug profiling by automated microscopy. Science 2004;306(5699):1194-1198 (Pubitemid 39489001)
29. Vogt A, Tamewitz A, Skoko J, et al. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. J Biol Chem 2005;280(19):19078-19086 (Pubitemid 41379614)
30. Adams CL, Kutsyy V, Coleman DA, et al. Compound classification using image-based cellular phenotypes. Methods Enzymol 2006;414:440-468 (Pubitemid 44716236)
31. Tao CY, Hoyt J, Feng Y. A support vector machine classifier for recognizing mitotic subphases using high-content screening data. J Biomol Screen 2007;12(4):490-496 (Pubitemid 46871833)
32. Gillet VJ, Khatib W, Willett P, et al. Combinatorial library design using a multiobjective genetic algorithm. J Chem Inf Comput Sci 2002;42(2):375-385 (Pubitemid 35355312)
33. Low J, Stancato L, Lee J, et al. Prioritizing hits from phenotypic high-content screens. Curr Opin Drug Discov Devel 2008;11(3):338-345 (Pubitemid 351572443)
34. Smellie A, Wilson CJ, Ng SC. Visualization and interpretation of high content screening data. J Chem Inf Model 2006;46(1):201-207
35. Goldberg IG, Allan C, Burel JM, et al. The Open Microscopy Environment (OME) Data Model and XML file: open tools for informatics and quantitative analysis in biological imaging. Genome Biol 2005;6(5):R47
36. Available from: http://www.ravkin.net/SBS/Invitation-Algorithm- Comparison.htm
37. Jenkins JL, Bender A, Davies JW. In silico target fishing: Predicting biological targets from chemical structure. Drug Discov Today Technol 2007;3:413-421
38. Nettles JH, Jenkins JL, Bender A, et al. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors. J Med Chem 2006;49(23):6802-6810
39. Maggiora GM. On outliers and activity cliffs - why QSAR often disappoints. J Chem Inf Model 2006;46(4):1535 (Pubitemid 44185680)